- ICH GCP
- US Clinical Trials Registry
- Researchers
- United Kingdom
- Erdheim-Chester Disease
Medical specialists from United Kingdom tagged as investigators in clinical trials studying Erdheim-Chester Disease
Total 17 results
-
Alastair Greystoke, DrSeen in:
- Newcastle, Freeman Hospital
- Newcastle, Great North Children's Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Anne Thomas, DrSeen in:
- Leicester, Leicester Royal Infirmary
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Antony Ng, DrSeen in:
- Bristol, Bristol Haematology and Oncology Centre
- Bristol, Bristol Royal Hospital for Children
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Bristi Basu, DrSeen in:
- Cambridge, Addenbrooke's Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Dan Palmer, DrSeen in:
- Wirral, Clatterbridge Cancer Centre
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Gary Middleton, ProfSeen in:
- Birmingham, University Hospital Birmingham
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
James Spicer, DrSeen in:
- London, Guy's Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Juliet Gray, ProfSeen in:
- Southampton, Southampton General Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Martin Elliott, DrSeen in:
- Leeds, Leeds General Infirmary
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Martin Foster, ProfSeen in:
- London, University College London Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Matthew Krebs, ProfSeen in:
- Manchester, The Christie Hospital
Trials:- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Solid Tumor;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Haematological Malignancy;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Patricia Roxburgh, DrSeen in:
- Glasgow, The Beatson Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Robert Jones, DrSeen in:
- Cardiff, Velindre Cancer Centre
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Sarah Danson, DrSeen in:
- Sheffield, Weston Park Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Sarah Pratap, DrSeen in:
- Oxford, Churchill Hospital
- Oxford, John Radcliffe Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Stefan Symeonides, DrSeen in:
- Edinburgh, Western General Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Vicky Coyle, ProfSeen in:
- Belfast, Belfast City Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
Clinical Trials on Erdheim-Chester Disease
-
Augusto VaglioRecruiting
-
National Cancer Institute (NCI)WithdrawnDabrafenib and Trametinib in Treating Patients With Erdheim Chester Disease With BRAF V600 MutationsErdheim-Chester DiseaseUnited States
-
Groupe Hospitalier Pitie-SalpetriereMemorial Sloan Kettering Cancer CenterUnknownLong-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease (LOVE)Erdheim-Chester DiseaseUnited States, France
-
Meyer Children's Hospital IRCCSRecruiting
-
Ospedale San RaffaeleTerminated
-
Memorial Sloan Kettering Cancer CenterRecruitingErdheim-Chester DiseaseUnited States
-
National Human Genome Research Institute (NHGRI)CompletedBRAF V600E MutationUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingSupportive Care Needs of CaregiversUnited States
-
Dana-Farber Cancer InstituteCelgeneActive, not recruitingLangerhans Cell Histiocytosis (LCH) | Histiocytoses Erdheim-chester Disease | Histiocytic Sarcoma (HS)United States
-
Memorial Sloan Kettering Cancer CenterCompletedLangerhans Cell Histiocytosis | Erdheim-Chester Disease | Histiocytic DisordersUnited States